KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Asset Writedowns and Impairment (2022 - 2025)

Historic Asset Writedowns and Impairment for Hims & Hers Health (HIMS) over the last 4 years, with Q3 2025 value amounting to $531000.0.

  • Hims & Hers Health's Asset Writedowns and Impairment changed N/A to $531000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $531000.0, marking a year-over-year increase of 28201.44%. This contributed to the annual value of $114000.0 for FY2024, which is 7342.66% down from last year.
  • Latest data reveals that Hims & Hers Health reported Asset Writedowns and Impairment of $531000.0 as of Q3 2025.
  • In the past 5 years, Hims & Hers Health's Asset Writedowns and Impairment registered a high of $1.1 million during Q3 2022, and its lowest value of $39000.0 during Q2 2024.
  • Its 4-year average for Asset Writedowns and Impairment is $439800.0, with a median of $429000.0 in 2023.
  • Over the last 5 years, Hims & Hers Health's Asset Writedowns and Impairment had its largest YoY gain of 7669.0% in 2024, and its largest YoY loss of 7669.0% in 2024.
  • Hims & Hers Health's Asset Writedowns and Impairment (Quarter) stood at $1.1 million in 2022, then tumbled by 61.0% to $429000.0 in 2023, then tumbled by 90.91% to $39000.0 in 2024, then skyrocketed by 1261.54% to $531000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $531000.0 for Q3 2025, versus $39000.0 for Q2 2024 and $100000.0 for Q1 2024.